Inventor · disambiguated record
Jingye Zhou
Also filed as: ZHOU JINGYE
17 granted patents·10 pending applications·79 citations·filing 2009–2025
92Inventor score
Files withLILLY CO ELI9TETRAPHASE PHARMACEUTICALS INC7ECCOGENE INC4ECCOGENE SHANGHAI CO LTD3ZHOU JINGYE3
Top patents by PatentIndex Score
27 records- 0195US11584751B1Substituted imidazoles as GLP-1 receptor agonistsECCOGENE SHANGHAI CO LTD·Filed 2021·Granted Feb 21, 2023·14 cites·25 claims
- 0294US8906887B2C7-fluoro substituted tetracycline compoundsZHOU JINGYE·Filed 2009·Granted Dec 9, 2014·13 cites·15 claims
- 0392US8796245B2C7-fluoro substituted tetracycline compoundsZHOU JINGYE·Filed 2012·Granted Aug 5, 2014·13 cites·16 claims
- 0492US8501716B2C7-fluoro substituted tetracycline compoundsZHOU JINGYE·Filed 2012·Granted Aug 6, 2013·14 cites·2 claims
- 0591US11780825B2Thyroid hormone receptor agonists and use thereofECCOGENE SHANGHAI CO LTD·Filed 2021·Granted Oct 10, 2023·3 cites·25 claims
- 0689US2025042843A1C7-fluoro substituted tetracycline compoundsTETRAPHASE PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0787US9624166B2Tetracycline compoundsDENG YONGHONG·Filed 2010·Granted Apr 18, 2017·7 cites·18 claims
- 0886US10287270B2Amino pyrimidine SSAO inhibitorsLILLY CO ELI·Filed 2018·Granted May 14, 2019·5 cites·33 claims
- 0986US10278970B2Amino pyrimidine compounds useful as SSAO inhibitorsLILLY CO ELI·Filed 2018·Granted May 7, 2019·4 cites·24 claims
- 1083US12037339B2Substituted imidazoles as GLP-1 receptor agonistsECCOGENE INC·Filed 2021·Granted Jul 16, 2024·1 cites·34 claims
- 1181US10793552B2Amino pyrimidine ssao inhibitorsLILLY CO ELI·Filed 2019·Granted Oct 6, 2020·1 cites·4 claims
- 1281US10471060B2Amino pyrimidine compounds useful as SSAO inhibitorsLILLY CO ELI·Filed 2019·Granted Nov 12, 2019·2 cites·19 claims
- 1380US2023122651A1C7-fluoro substituted tetracycline compoundsTETRAPHASE PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1479US10464928B2Amino pyrimidine SSAO inhibitorsLILLY CO ELI·Filed 2019·Granted Nov 5, 2019·2 cites·16 claims
- 1576US2021122709A1C7-fluoro substituted tetracycline compoundsTETRAPHASE PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1675US2025059192A1Substituted imidazoles as glp-1 receptor agonistsECCOGENE INC·Filed 2024·Application pending·0 cites
- 1772US12291518B2Thyroid hormone receptor agonists and use thereofECCOGENE INC·Filed 2023·Granted May 6, 2025·0 cites·4 claims
- 1870US2020055813A1C7-fluoro substituted tetracycline compoundsTETRAPHASE PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1967US2015274643A1C7-fluoro substituted tetracycline compoundsTETRAPHASE PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2065US2025320197A1Thyroid hormone receptor agonists and use thereofECCOGENE INC·Filed 2025·Application pending·0 cites
- 2164US2017275244A1C7-Fluoro Substituted Tetracycline CompoundsTETRAPHASE PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2256US2022348564A1Phenyl-[1,3]dioxolo[4,5-c]pyridinyl-phenyl-, phenyl-[1,3]dioxolo[4,5-c]pyridinyl-heteroaryl-, or phenyl-(1,3)dioxo[4,5-c]pyridinyl-piperidinyl-methyl-oxetanylmethyl-1h-benzo[d]imidazole-carboxylic acid derivatives and methods of using sameECCOGENE SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 2346US2017334841A1Tetracycline compoundsTETRAPHASE PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 2443US10196385B2Tetrahydropyranyl benzamide derivativesLILLY CO ELI·Filed 2016·Granted Feb 5, 2019·0 cites·22 claims
- 2543US9822101B1Pyrazole compoundsLILLY CO ELI·Filed 2016·Granted Nov 21, 2017·0 cites·6 claims
- 2642US10807971B2Pyrrolidinone compoundsLILLY CO ELI·Filed 2017·Granted Oct 20, 2020·0 cites·9 claims
- 2729US9861613B2GPR142 agonist compoundsLILLY CO ELI·Filed 2015·Granted Jan 9, 2018·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Jingye Zhou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →